Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 10 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

30%

3 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A

6(60.0%)

Phase 4

3(30.0%)

Phase 1

1(10.0%)

10Total

N/A(6)

Phase 4(3)

Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (10)

Showing 10 of 10 trials

NCT04031014Not ApplicableCompleted

High Intensity Focused Electromagnetic Field Device for Urinary Incontinence

Role: lead

NCT04270526Phase 4Completed

Minimizing Pain During Office Intradetrussor Botox Injection

Role: lead

NCT02715648Not ApplicableUnknown

Using Phenazopyridine for In-office Cystoscopy

Role: lead

NCT01905137Not ApplicableUnknown

Botulinum Toxin Type A Versus Saline Trigger Point Injections for Myofascial Pelvic Pain

Role: lead

NCT02304016Not ApplicableUnknown

Evaluation of the Effect of Pelvic Floor Physical Therapy on Patients With 3rd and 4th Degree Obstetrical Lacerations

Role: lead

NCT02750878Not ApplicableUnknown

Surgical Consent Process for Trans-obturator Tape Slings.

Role: lead

NCT02742389Not ApplicableCompleted

Urodynamic Testing: Can we Improve Patient Experience?

Role: lead

NCT03033160Phase 4Unknown

Vaginal Estrogen for Asymptomatic Microscopic Hematuria

Role: lead

NCT01522261Phase 1Unknown

The Surgical Benefit and Pt.Tolerability Between Two Different Bowel Cleansing Regimens Performed Prior to Pelvic Reconstructive Surgery. Does One Bowel Cleansing Regimen Improve the Surgeons Visual Field Significantly Better Than the Other.

Role: lead

NCT00676273Phase 4Unknown

TVT-Secur Versus TVT-Obturator: A Randomized Trial of Suburethral Sling Operative Procedures

Role: lead

All 10 trials loaded